Benjamin Krishna News Today

SARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache and depression. New research shows that in Long COVID patients, IFN-y production persists until symptoms improve, highlighting a potential biomarker and a target for therapies.

SARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache and depression.

Persistently high levels of interferon gamma could explain some of the condition’s symptoms.

Infection with the COVID-19 virus triggers the production of an immune system protein that's long been associated with fatigue, muscle ache and depression.

A study followed a group of patients with Long COVID fatigue for over two years.

Current long Covid treatment involves treating symptoms and not the underlying cause, but there’s hope drugs that specifically target long Covid are on the way since a potential cause has been identified.

SARS-CoV-2 triggers the production of the antiviral protein IFN-γ, which is associated with fatigue, muscle ache and depression. New research shows that in Lon

A study followed a group of patients with Long COVID fatigue for over two years.